DMDmitry ManuilovMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MDView Video
DMDouglas MayersMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MDView Video
MMMatthew McClureMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021STOP Agents - M. McClure, MDView Video
LFLeigh FeltonBSc, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Antisense Oligos - L. Felton, BSc, PhDView Video
LSLuisa StammMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Core Inhibitors (Capsid Assembly Modulators) - L. Stamm, MD, PhDView Video
SUStephan UrbanPhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Biological Insights Taught by Clinical Responses to Novel Hbv/Hdv Drugs - S. Urban, PhDView Video
PMPoonam MishraMD, MPH, FAASLDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Safety Monitoring during HBV Clinical Trials and after Antiviral Discontinuation -P. Mishra, MDView Video
HJHarry JanssenMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021How to Handle Flares in HBV Trials With Novel Agents - H. Janssen, MD, PhDView Video
MCMarkus CornbergMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021Outcomes After NUC Therapy Discontinuation - M. Cornberg, MDView Video
MPMarion PetersMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021HBsAg Loss: A Predictor of Long-Term Clinical Outcomes - M. Peters, MDView Video
EBEleanor BarnesPhD, FRCP, F. Med. Sci.VideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci.View Video
FDFrancisco Diaz-MitomaMD, PhDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2021VBI-2601: Immunotherapeutic HBV Vaccine Candidate Overview - F. Diaz-Mitoma, MD, PhDView Video
